vs
CODEXIS, INC.(CDXS)与森馨科技(SXT)财务数据对比。点击上方公司名可切换其他公司
森馨科技的季度营收约是CODEXIS, INC.的11.2倍($435.8M vs $38.9M)。CODEXIS, INC.净利率更高(24.7% vs 10.1%,领先14.5%)。CODEXIS, INC.同比增速更快(81.3% vs 54.2%)。过去两年CODEXIS, INC.的营收复合增速更高(51.0% vs 3.9%)
科迪西斯是一家专注于蛋白质工程的企业,核心业务是开发可应用于制药、食品及医疗领域的酶制剂,依托自身技术优势为相关行业提供高性能的生物催化解决方案,助力生命科学与食品加工领域的技术升级。
森馨科技是总部位于美国威斯康星州密尔沃基的全球化色素、香精香料生产商及销售商,产品广泛应用于食品饮料、医药、化妆品、家居个护、特种印刷成像、计算机成像及工业着色等多个领域,旗下设有香精香料事业部与色素事业部两大核心业务板块。
CDXS vs SXT — 直观对比
营收规模更大
SXT
是对方的11.2倍
$38.9M
营收增速更快
CDXS
高出27.2%
54.2%
净利率更高
CDXS
高出14.5%
10.1%
两年增速更快
CDXS
近两年复合增速
3.9%
损益表 — Q4 2025 vs Q1 2026
| 指标 | ||
|---|---|---|
| 营收 | $38.9M | $435.8M |
| 净利润 | $9.6M | $44.2M |
| 毛利率 | 94.8% | — |
| 营业利润率 | 27.1% | 15.3% |
| 净利率 | 24.7% | 10.1% |
| 营收同比 | 81.3% | 54.2% |
| 净利润同比 | 192.5% | 28.2% |
| 每股收益(稀释后) | $0.13 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CDXS
SXT
| Q1 26 | — | $435.8M | ||
| Q4 25 | $38.9M | $393.4M | ||
| Q3 25 | $8.6M | $412.1M | ||
| Q2 25 | $15.3M | $414.2M | ||
| Q1 25 | $7.5M | $392.3M | ||
| Q4 24 | $21.5M | $376.4M | ||
| Q3 24 | $12.8M | $392.6M | ||
| Q2 24 | $8.0M | $403.5M |
净利润
CDXS
SXT
| Q1 26 | — | $44.2M | ||
| Q4 25 | $9.6M | $25.5M | ||
| Q3 25 | $-19.6M | $37.0M | ||
| Q2 25 | $-13.3M | $37.6M | ||
| Q1 25 | $-20.7M | $34.5M | ||
| Q4 24 | $-10.4M | $30.1M | ||
| Q3 24 | $-20.6M | $32.7M | ||
| Q2 24 | $-22.8M | $30.9M |
毛利率
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | 94.8% | 31.4% | ||
| Q3 25 | 71.3% | 34.3% | ||
| Q2 25 | 86.3% | 34.5% | ||
| Q1 25 | 63.8% | 33.6% | ||
| Q4 24 | 83.0% | 31.7% | ||
| Q3 24 | 66.4% | 33.2% | ||
| Q2 24 | 56.6% | 32.4% |
营业利润率
CDXS
SXT
| Q1 26 | — | 15.3% | ||
| Q4 25 | 27.1% | 9.7% | ||
| Q3 25 | -220.3% | 14.0% | ||
| Q2 25 | -83.9% | 13.9% | ||
| Q1 25 | -271.6% | 13.6% | ||
| Q4 24 | -34.2% | 11.2% | ||
| Q3 24 | -129.0% | 12.9% | ||
| Q2 24 | -284.9% | 12.3% |
净利率
CDXS
SXT
| Q1 26 | — | 10.1% | ||
| Q4 25 | 24.7% | 6.5% | ||
| Q3 25 | -228.1% | 9.0% | ||
| Q2 25 | -86.6% | 9.1% | ||
| Q1 25 | -274.3% | 8.8% | ||
| Q4 24 | -48.4% | 8.0% | ||
| Q3 24 | -160.8% | 8.3% | ||
| Q2 24 | -285.2% | 7.7% |
每股收益(稀释后)
CDXS
SXT
| Q1 26 | — | $1.04 | ||
| Q4 25 | $0.13 | $0.60 | ||
| Q3 25 | $-0.22 | $0.87 | ||
| Q2 25 | $-0.16 | $0.88 | ||
| Q1 25 | $-0.25 | $0.81 | ||
| Q4 24 | $-0.12 | $0.71 | ||
| Q3 24 | $-0.29 | $0.77 | ||
| Q2 24 | $-0.32 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $78.2M | $38.5M |
| 总债务越低越好 | $40.1M | $767.8M |
| 股东权益账面价值 | $50.5M | $1.2B |
| 总资产 | $147.8M | $2.3B |
| 负债/权益比越低杠杆越低 | 0.79× | 0.63× |
8季度趋势,按日历期对齐
现金及短期投资
CDXS
SXT
| Q1 26 | — | $38.5M | ||
| Q4 25 | $78.2M | $36.5M | ||
| Q3 25 | $58.7M | $42.7M | ||
| Q2 25 | $66.3M | $56.7M | ||
| Q1 25 | $59.8M | $32.6M | ||
| Q4 24 | $73.5M | $26.6M | ||
| Q3 24 | $90.3M | $37.0M | ||
| Q2 24 | $73.2M | $30.3M |
总债务
CDXS
SXT
| Q1 26 | — | $767.8M | ||
| Q4 25 | $40.1M | $709.2M | ||
| Q3 25 | $39.7M | — | ||
| Q2 25 | $39.4M | — | ||
| Q1 25 | $29.2M | — | ||
| Q4 24 | $28.9M | $613.5M | ||
| Q3 24 | $28.6M | — | ||
| Q2 24 | $28.4M | — |
股东权益
CDXS
SXT
| Q1 26 | — | $1.2B | ||
| Q4 25 | $50.5M | $1.2B | ||
| Q3 25 | $38.5M | $1.2B | ||
| Q2 25 | $55.6M | $1.2B | ||
| Q1 25 | $49.6M | $1.1B | ||
| Q4 24 | $66.9M | $1.1B | ||
| Q3 24 | $73.4M | $1.1B | ||
| Q2 24 | $61.4M | $1.1B |
总资产
CDXS
SXT
| Q1 26 | — | $2.3B | ||
| Q4 25 | $147.8M | $2.2B | ||
| Q3 25 | $124.0M | $2.2B | ||
| Q2 25 | $138.2M | $2.2B | ||
| Q1 25 | $128.9M | $2.1B | ||
| Q4 24 | $149.0M | $2.0B | ||
| Q3 24 | $148.2M | $2.0B | ||
| Q2 24 | $132.0M | $2.0B |
负债/权益比
CDXS
SXT
| Q1 26 | — | 0.63× | ||
| Q4 25 | 0.79× | 0.59× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.43× | 0.58× | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $20.1M | — |
| 自由现金流经营现金流 - 资本支出 | $19.6M | — |
| 自由现金流率自由现金流/营收 | 50.3% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 2.09× | — |
| 过去12个月自由现金流最近4个季度 | $-23.8M | — |
8季度趋势,按日历期对齐
经营现金流
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | $20.1M | $44.6M | ||
| Q3 25 | $-7.7M | $44.0M | ||
| Q2 25 | $-18.0M | $48.3M | ||
| Q1 25 | $-13.8M | $-9.0M | ||
| Q4 24 | $-16.5M | $21.4M | ||
| Q3 24 | $-13.0M | $76.8M | ||
| Q2 24 | $-12.2M | $43.8M |
自由现金流
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | $19.6M | $12.9M | ||
| Q3 25 | $-7.9M | $24.2M | ||
| Q2 25 | $-20.5M | $27.1M | ||
| Q1 25 | $-15.1M | $-25.8M | ||
| Q4 24 | $-18.2M | $-1.7M | ||
| Q3 24 | $-14.0M | $63.6M | ||
| Q2 24 | $-12.6M | $32.0M |
自由现金流率
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | 50.3% | 3.3% | ||
| Q3 25 | -91.7% | 5.9% | ||
| Q2 25 | -133.6% | 6.5% | ||
| Q1 25 | -199.6% | -6.6% | ||
| Q4 24 | -85.0% | -0.5% | ||
| Q3 24 | -109.0% | 16.2% | ||
| Q2 24 | -157.5% | 7.9% |
资本支出强度
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 8.0% | ||
| Q3 25 | 2.1% | 4.8% | ||
| Q2 25 | 16.4% | 5.1% | ||
| Q1 25 | 16.7% | 4.3% | ||
| Q4 24 | 8.3% | 6.1% | ||
| Q3 24 | 7.8% | 3.4% | ||
| Q2 24 | 5.0% | 2.9% |
现金转化率
CDXS
SXT
| Q1 26 | — | — | ||
| Q4 25 | 2.09× | 1.75× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.28× | ||
| Q1 25 | — | -0.26× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | — | 2.35× | ||
| Q2 24 | — | 1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图